Medical Condition News

RSS

ECLS trial demonstrates potential of blood test for early lung cancer detection

Oncimmune Holdings plc, a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.

12 Sep 2019

Asia-Pacific’s eminent minds to showcase latest breakthroughs in stroke research

More than 450 of the Asia-Pacific’s eminent minds in stroke will converge on Canberra this week to showcase the latest breakthroughs in research contributing to our understanding of stroke.

12 Sep 2019

Raising Awareness of Coeliac Disease with Coeliac UK

An interview with Norma McGough from Coeliac UK, debunking some of the common myths surrounding celiac disease and helping to raise awareness of the condition

12 Sep 2019

Cancer disease incidence and severity influenced by gene mutation, tissue location

The KRAS gene is one of the commonly mutated genes in cancer. More than 40 percent of colorectal cancers have a mutated KRAS gene, or oncogene, that is at least partially responsible for cancer development.

12 Sep 2019

Georgia Cancer Center awarded $6 million grant to improve access to clinical trials

The Georgia Cancer Center at Augusta University has been awarded a six-year $6 million grant from the National Cancer Institute to lead a statewide initiative that improves access to innovative clinical trials for a variety of cancers to underserved individuals across Georgia.

12 Sep 2019

New insight into origin of diabetes in overweight patients

In Switzerland, more than 400,000 people suffer from type 2 diabetes, a serious metabolic disorder that is constantly increasing. Obesity, by promoting the resistance to the action of insulin - one of the hormones that regulate blood sugar levels - is a major risk factor.

12 Sep 2019

Insulin drug could treat glioblastoma

A research team from the University of Georgia's Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer.

12 Sep 2019

Electrical-first strategy for atrial fibrillation results in shorter ED length of stay

A multicenter randomized controlled clinical trial confirms that both chemical-first and electrical-first approaches are effective strategies for acute atrial fibrillation; however, an electrical-first strategy results in a significantly shorter emergency department length of stay.

12 Sep 2019

CAR T-cell therapy may be viable treatment option for heart disease

CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients' own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease.

12 Sep 2019

Study identifies inhibitor that protects cells from toxic DUX4 effects

About one in 8,000 people have facioscapulohumeral muscular dystrophy, according to a 2014 study, which is relatively common in the world of genetic diseases.

11 Sep 2019

A gene that acts as master regulator of schizophrenia identified

Using computational tools to investigate gene transcription networks in large collections of brain tissues, a scientific team has identified a gene that acts as a master regulator of schizophrenia during early human brain development.

11 Sep 2019

LMRI scientists discover cause of debilitating eye disease

Scientists at the Lowy Medical Research Institute have discovered one cause of a progressive, debilitating eye disease called macular telangiectasia type 2 (MacTel).

11 Sep 2019

First genetic cause for a rare eye disease discovered

John A. Moran Eye Center physician-researcher Paul S. Bernstein, MD, PhD, and his patients at the University of Utah played a key role in the recent discovery of the first genetic cause for a rare eye disease.

11 Sep 2019

Brain changes may help track people most likely to develop dementia

Even before dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

11 Sep 2019

Pupil dilation provides clues to future Alzheimer’s risk

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that affects the quality of life of those affected by the disease. The most common form of dementia, Alzheimer’s disease negatively impacts thinking, memory, behavior. Currently, there is no cure for Alzheimer’s disease but treatments can slow its progression.

11 Sep 2019

Novel protein biomarker can help improve dementia risk prediction

Identifying those who are at risk of dementia, a type of neurodegenerative disease, is crucial for early treatment and development of new therapies, a new study suggests.

11 Sep 2019

New model for vaginal microbiome transplantation

Bacterial vaginosis is a condition affecting thousands of women worldwide, and is associated not only with vaginal symptoms but with pregnancy-related complications including preterm labor and stillbirth. Now researchers have come up with an effective way to replace the unhealthy vaginal microflora with a ready-to-use microbiome – called a vaginal microbiome transplantation (VMT).

11 Sep 2019

Taller people at lower risk for type 2 diabetes

A new German study has found that taller people are at a lower risk of developing type 2 diabetes. The study titled, “Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors,” was published in the latest issue of the journal Diabetologia.

11 Sep 2019

Quick action can save lives of people with severe hypoglycemia

People with diabetes and their friends and relatives will be better prepared to spot the signs of dangerously low blood sugar using new resources the Hormone Health Network has introduced.

11 Sep 2019

Calcium channel blockers may help effectively treat memory loss in Alzheimer's disease

Alzheimer's disease (AD) is the most common cause of dementia but the changes in brain cell function underlying memory loss remains poorly understood.

11 Sep 2019